[Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Vidal.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Inbred (C57BL6 X CBA) F1 mice or outbred Ico: OF1 (Caw) mice received a weekly injection of rat erythrocytes for 2-3 months and the (IgM and IgG) antibody levels to autologous erythrocytes were measured by ELISA. No autoantibodies were found in serum but the erythrocyte-bound IgM and IgG antibodies rose initially and levelled off afterwards (usually from day 14 onwards). The anti-rat erythrocyte antibody response also rose sharply at the beginning and eventually levelled off. This suggests the existence of one or several homeostatic mechanisms. Ico: OF1 (Caw) mice received a weekly injection of E. coli lipopolysaccharide (LPS), 75 micrograms/mouse, for 7 weeks, and the autoantibody levels to autologous erythrocytes and to ssDNA were measured by ELISA. While LPS readily increased the anti-ssDNA autoantibody level, it failed to elicit detectable concentrations of erythrocyte-bound antibodies. Nevertheless, LPS enhanced the response to autologous erythrocytes triggered by a suboptimal dose of rat erythrocytes. This suggests that LPS induces autoantibodies to those antigens that have already initiated an immune response.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.